Non-invasive diagnostic method for interstitial cystitis and bladder cancer
US6008003A · kind A · utility
82Cited by
2References
25Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 28, 1997 |
| Grant date | Dec 28, 1999 |
| Priority date | — |
| Expiry date | Oct 28, 2017 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2800/348
- WIPO fieldMeasurement
- WIPO sectorInstruments
Abstract
Disclosed is a method of diagnosing or monitoring interstitial cystitis or bladder cancer in a mammal. The method comprises analyzing urine of the mammal for the concentration of a urine-soluble protein selected from the group consisting of neurotrophin-3, nerve growth factor, glial cell line-derived neurotrophic factor, tryptase, and combinations thereof.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.